PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
